Physician profile

Yevgeniy A Khavkin

Neurological Surgery · Las Vegas, NV

NPI 1922055128

$577,031.38

in general payments reported to CMS, 2019-2025

42 companies · $75.24 in 2025

The $75.24 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).

See the full distribution for Neurological Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Royalty Or License$156,056.53
Travel and Lodging$5,619.47
Food and Beverage$4,610.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Integrity Implants INC. $399,763.54 2019-2022 Flarehawk
Integrity Implants INC. Dba Accelus $152,058.35 2023-2024 Flarehawk
Precision Spine, INC. $10,075.56 2020-2024
Stryker Corporation $6,316.06 2019-2023 Everest Spinal System, Yukon Oct Spinal System, Cascadia Interbody System
Nevro Corp. $2,752.15 2020-2024 Senza
Boston Scientific Corporation $2,021.16 2021-2024 Wavewriter Alpha Prime 16, Coveredge 32, Spectra Wavewriter
Si-Bone, INC. $1,000.38 2019-2023
Providence Medical Technology, INC. $545.31 2021-2022
Abbott Laboratories $324.69 2019-2022
Zimmer Biomet Holdings, INC. $284.52 2019-2020
Painteq LLC $275.42 2024 Painteq
Medtronic USA, INC. $226.25 2019-2020
Cerapedics INC. $160.73 2023 I-Factor Peptide Enhanced Bone Graft
Medtronic, INC. $133.47 2021
Depuy Synthes Sales INC. $124.85 2023 Acis Proti 360 Hl
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Kls-Martin L.P. $93.09 2019-2022
Biocomposites INC $91.63 2024-2025 Stimulan
Allergan, INC. $86.05 2019-2021
Seaspine Orthopedics Corporation $84.57 2022
Merz North America, INC. $76.85 2019-2020
Astrazeneca Pharmaceuticals LP $63.26 2023 Brilinta, Andexxa
Galderma Laboratories, L.P. $52.70 2019
Sanara Medtech INC. $38.57 2023-2024 Celleraterx
Curonix LLC $36.27 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Impel Pharmaceuticals INC. $30.18 2023 Trudhesa
Upsher-Smith Laboratories LLC $28.59 2021
Olympus America INC. $23.53 2019
Smith+Nephew, INC. $22.98 2023 Pico
Innovation Technologies INC $22.35 2024 Irrisept
Livanova USA, INC. $21.07 2019
Aerin Medical INC. $20.73 2019
Sunovion Pharmaceuticals INC. $20.53 2020
Bioventus LLC $19.31 2024 Bonescalpel & Sonicone (O.R.)
Biogen, INC. $18.03 2021
Nuvasive, INC. $17.99 2019
Mallinckrodt Enterprises LLC $17.91 2019
Stimwave Technologies Incorporated $16.91 2022
Arteriocyte Medical Systems, INC. $15.20 2020
Biohaven Pharmaceuticals, INC. $13.46 2021
Kowa Pharmaceuticals America, INC. $13.20 2023 Seglentis
Amgen INC. $12.77 2021
Nalu Medical, INC. $11.21 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Yevgeniy A Khavkin

$577,031.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Integrity Implants INC.
Context
The $75.24 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).

https://glasscript.com/doctor/178317/yevgeniy-a-khavkin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.